Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease

Alexandros G.Sfakianakis shared this article with you from Inoreader Virtual screening and network pharmacology-based synergistic mechanism identification of multiple components contained in Guanxin V against coronary artery disease Μέσω BMC Complementary and Alternative Medicine - Latest Articles Guanxin V (GXV), a traditional Chinese medicine (TCM), has been widely used to treat coronary artery disease (CAD) in clinical practice in China. However, research on the active components and underlying mecha... View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.